The changing role of HIV-associated oral candidiasis in the era of HAART.

Abstract

Oral candidiasis is the most common fungal opportunistic infection to affect the oral cavity among HIV patients. The advent of highly active antiretroviral therapy (HAART) has changed the epidemiology of candidiasis, with many studies reporting a decrease in prevalence. However, some studies report rare cases of increased prevalence. This systematic review clarifies the role of oral candidiasis in the HAART era as a marker of immune status and successful therapy for the HIV-infected population.

• Authors: Christopher Patuwo, Keane Young, Meng Lin, Vanessa Pardi, Ramiro M Murata
• Journal: Journal of the California Dental Association (J Calif Dent Assoc) Vol. 43 Issue 2 Pg. 87-92 (Feb 2015) ISSN: 1043-2256 [Print] United States
• PMID: 25868223 (Publication Type: Journal Article, Research Support, N.I.H., Extramural, Review, Systematic Review)

Chemical References

• Anti-HIV Agents
• Anti-Retroviral Agents
• Reverse Transcriptase Inhibitors

Topics

• AIDS-Related Opportunistic Infections (prevention & control)
• Anti-HIV Agents (therapeutic use)
• Anti-Retroviral Agents (therapeutic use)
• Antiretroviral Therapy, Highly Active
• Candidiasis, Oral (prevention & control)
• HIV Infections (drug therapy, immunology)
• Humans
• Reverse Transcriptase Inhibitors (therapeutic use)